Investments (Tables)
|
6 Months Ended |
Sep. 30, 2018 |
|---|
| Equity Method Investments, Cost Method Investments, and Investments in Debt and Equity [Abstract] |
|
| Carrying Amount of Investments, By Category |
The carrying amounts of investments, by category, at September 30, 2018 and March 31, 2018 were as follows: | | | | | | | | | | | | September 30,
2018 | | March 31,
2018 | | | (Amounts in millions) | Equity method investments | | $ | 124.7 |
| | $ | 127.0 |
| Available-for-sale securities | | 4.6 |
| | 7.3 |
| Cost method investments | | 0.5 |
| | 30.6 |
| | | $ | 129.8 |
| | $ | 164.9 |
|
|
| Schedule of Equity Method Investments [Line Items] |
|
| Carrying Amount of Equity Method Investments |
The carrying amounts of equity method investments at September 30, 2018 and March 31, 2018 were as follows: | | | | | | | | | | | | September 30,
2018 | | | | | Equity Method Investee | Ownership Percentage | | September 30,
2018 | | March 31,
2018 | | | | (Amounts in millions) | Pop | 50.0% | | $ | 95.3 |
| | $ | 91.3 |
| Other | Various | | 29.4 |
| | 35.7 |
| | | | $ | 124.7 |
| | $ | 127.0 |
|
|
| Equity Method Investee, Income (Loss) |
Equity interests in equity method investments for the three and six months ended September 30, 2018 and 2017 were as follows (income (loss)): | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | September 30, | | September 30, | Equity Method Investee | 2018 | | 2017 | | 2018 | | 2017 | | (Amounts in millions) | EPIX(1) | $ | — |
| | $ | — |
| | $ | — |
| | $ | 4.0 |
| Pop | (0.3 | ) | | 0.5 |
| | (1.1 | ) | | (2.5 | ) | Other | (11.4 | ) | | (13.2 | ) | | (16.7 | ) | | (22.5 | ) | | $ | (11.7 | ) | | $ | (12.7 | ) | | $ | (17.8 | ) | | $ | (21.0 | ) |
______________ | | (1) | In May 2017, the Company sold all of its 31.15% equity interest in EPIX. The Company recorded a gain before income taxes of approximately $201.0 million which is reflected in the gain (loss) on investments line item in the unaudited condensed consolidated statement of operations for the six months ended September 30, 2017. Prior to the sale of its interest in EPIX, the Company had accounted for such interest as an equity method investment. |
|
| Gain (Loss) on Investments |
The following table summarizes the components of the gain (loss) on investments, as previously described in the respective sections above:
| | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | September 30, | | September 30, | | 2018 | | 2017 | | 2018 | | 2017 | | (Amounts in millions) | Impairments of long-term investments and other assets | $ | (34.2 | ) | | $ | — |
| | $ | (34.2 | ) | | $ | — |
| Unrealized losses on available-for-sale securities held as of September 30, 2018 | (1.9 | ) | | — |
| | (2.8 | ) | | — |
| Gain on sale of EPIX | — |
| | — |
| | — |
| | 201.0 |
| | $ | (36.1 | ) | | $ | — |
| | $ | (37.0 | ) | | $ | 201.0 |
|
|
| Pop |
|
| Schedule of Equity Method Investments [Line Items] |
|
| Summarized Balance Sheet |
The following table presents summarized balance sheet data as of September 30, 2018 and March 31, 2018 for Pop: | | | | | | | | | | September 30,
2018 | | March 31,
2018 | | (Amounts in millions) | Current assets | $ | 73.5 |
| | $ | 48.2 |
| Non-current assets | $ | 190.6 |
| | $ | 191.6 |
| Current liabilities | $ | 46.5 |
| | $ | 37.2 |
| Non-current liabilities(1) | $ | 716.5 |
| | $ | 654.9 |
| Redeemable preferred stock(1) | $ | 692.7 |
| | $ | 638.4 |
|
_________________________ | | (1) | Non-current liabilities includes mandatorily redeemable preferred stock units. |
|
| Summarized Statement of Income |
The following table presents the summarized statements of operations for the three and six months ended September 30, 2018, and 2017 for Pop and a reconciliation of the net loss reported by Pop to equity interest income (loss) recorded by the Company: | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | September 30, | | September 30, | | 2018 | | 2017 | | 2018 | | 2017 | | | | | | | Revenues | $ | 25.9 |
| | $ | 28.3 |
| | $ | 51.5 |
| | $ | 53.0 |
| Expenses: | | | | | | | | Cost of services | 12.4 |
| | 13.8 |
| | 25.5 |
| | 30.8 |
| Selling, marketing, and general and administration | 11.5 |
| | 11.1 |
| | 23.4 |
| | 23.2 |
| Depreciation and amortization | 2.0 |
| | 2.0 |
| | 4.0 |
| | 4.0 |
| Operating income (loss) | — |
| | 1.4 |
| | (1.4 | ) | | (5.0 | ) | Interest expense, net | 0.5 |
| | 0.4 |
| | 0.9 |
| | 0.5 |
| Accretion of redeemable preferred stock units(1) | 22.6 |
| | 19.3 |
| | 44.4 |
| | 37.9 |
| Total interest expense, net | 23.1 |
| | 19.7 |
| | 45.3 |
| | 38.4 |
| Net loss | $ | (23.1 | ) | | $ | (18.3 | ) | | $ | (46.7 | ) | | $ | (43.4 | ) | Reconciliation of net loss reported by Pop to equity interest income (loss): | | | | | | | | Net loss reported by Pop | $ | (23.1 | ) | | $ | (18.3 | ) | | $ | (46.7 | ) | | $ | (43.4 | ) | Ownership interest in Pop | 50 | % | | 50 | % | | 50 | % | | 50 | % | The Company's share of net loss | (11.6 | ) | | (9.2 | ) | | (23.4 | ) | | (21.7 | ) | Accretion of dividend and interest income on redeemable preferred stock units(1) | 11.3 |
| | 9.7 |
| | 22.2 |
| | 19.0 |
| Elimination of the Company's share of profits on licensing sales to Pop | (0.1 | ) | | (0.1 | ) | | (0.2 | ) | | (0.2 | ) | Realization of the Company’s share of profits on licensing sales to Pop | 0.1 |
| | 0.1 |
| | 0.3 |
| | 0.4 |
| Total equity interest income (loss) recorded | $ | (0.3 | ) | | $ | 0.5 |
| | $ | (1.1 | ) | | $ | (2.5 | ) |
___________________ | | (1) | Accretion of mandatorily redeemable preferred stock units represents Pop's 10% dividend and the amortization of discount on its mandatorily redeemable preferred stock units held by the Company and the other interest holder. The Company recorded its share of this expense as income from the accretion of dividend and discount on mandatorily redeemable preferred stock units within equity interest loss. |
|
| Other |
|
| Schedule of Equity Method Investments [Line Items] |
|
| Summarized Balance Sheet |
Summarized financial information for the Company's "other equity method investees", on an aggregate basis, is set forth below: | | | | | | | | | | September 30,
2018 | | March 31,
2018 | | (Amounts in millions) | Current assets | $ | 181.4 |
| | $ | 232.7 |
| Non-current assets | $ | 59.5 |
| | $ | 130.0 |
| Current liabilities | $ | 149.9 |
| | $ | 201.5 |
| Non-current liabilities | $ | 10.2 |
| | $ | 45.0 |
|
|
| Summarized Statement of Income |
| | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | September 30, | | September 30, | | 2018 | | 2017 | | 2018 | | 2017 | | (Amounts in millions) | Revenues | $ | 30.7 |
| | $ | 49.3 |
| | $ | 53.4 |
| | $ | 88.1 |
| Gross profit | $ | 15.3 |
| | $ | 9.3 |
| | $ | 19.6 |
| | $ | 18.0 |
| Net loss | $ | (34.9 | ) | | $ | (32.5 | ) | | $ | (55.3 | ) | | $ | (62.4 | ) |
|